Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10736963 Methods for detecting tissue infiltrating NK cells
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10736963
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 29 Apr, 2023
Infobox
Patent Citations
US Patent 10519234 NKp46 binding proteins
0
"update citations for inverse infoboxes"
Golden AI
edited on 29 Apr, 2023
Infobox
Patent Citations
US Patent 10329348 Treatment of cancers using anti-NKG2A agents
0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Apr, 2023
Infobox
Patent Citations
US Patent 10160810 Monoclonal antibodies against NKG2A
0
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 4 Apr, 2023
Infobox
Patent Citations
US Patent 10344087 Treatment of peripheral T cell lymphoma
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 28 Sep, 2022
Infobox
Patent Citations
US Patent 10253095 Anti-KIR combination treatments and methods
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 10577416 Mica binding agents
0
"Entity importer update"
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
0
Patent Applicant
Innate Pharma
0
Current Assignee
Innate Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10736963
0
Date of Patent
August 11, 2020
0
Patent Application Number
15747190
0
Date Filed
July 4, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10736963
0
Patent Citations
US Patent 10059765 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
0
US Patent 10113003 Multispecific NK engager proteins
0
US Patent 10160810 Monoclonal antibodies against NKG2A
0
US Patent 10174112 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
0
US Patent 10253095 Anti-KIR combination treatments and methods
0
US Patent 10329348 Treatment of cancers using anti-NKG2A agents
0
US Patent 10344087 Treatment of peripheral T cell lymphoma
0
US Patent 10519234 NKp46 binding proteins
0
US Patent 10577416 Mica binding agents
0
Patent Primary Examiner
Michail A Belyavskyi
0
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 10160810 Monoclonal antibodies against NKG2A
0
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10059765 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
0
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations
US Patent 10329348 Treatment of cancers using anti-NKG2A agents
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10736963
Edits on 6 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 6 Feb, 2022
Edits made to:
Infobox
(
+18
properties)
US Patent 10736963 Methods for detecting tissue infiltrating NK cells
Infobox
Is a
Patent
Patent applicant
Innate Pharma
Current assignee
Innate Pharma
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10736963
Date of patent
August 11, 2020
Patent application number
15747190
Date Filed
July 4, 2016
Patent citations
US Patent 10059765 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
US Patent 10113003 Multispecific NK engager proteins
US Patent 10160810 Monoclonal antibodies against NKG2A
US Patent 10174112 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
US Patent 10253095 Anti-KIR combination treatments and methods
US Patent 10329348 Treatment of cancers using anti-NKG2A agents
US Patent 10344087 Treatment of peripheral T cell lymphoma
US Patent 10519234 NKp46 binding proteins
US Patent 10577416 Mica binding agents
Patent primary examiner
Michail A Belyavskyi
Find more entities like US Patent 10736963 Methods for detecting tissue infiltrating NK cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE